Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Pressure BioSciences Inc.

Pressure BioSciences Announces Second Contract for Toll Manufacturing of a CBD Nanoemulsion Product Using Its Proprietary Ultra Shear Technology Platform
From Pressure BioSciences Inc.
Via AccessWire
Topics Cannabis
Exposures Cannabis
Tickers PBIO
Pressure BioSciences to Expand on Upcoming Release of CBD Nanoemulsion Oral Spray at July 6th Emerging Growth Conference - Annual Revenue to PBI Expected to Exceed $1M
From Pressure BioSciences Inc.
Via AccessWire
Tickers PBIO
Pressure BioSciences to Participate in FORCE Family Office June 30th Webinar: Revolutionizing the Development of Plant-Based Food Products
From Pressure BioSciences Inc.
Via AccessWire
Tickers PBIO
Pressure BioSciences Announces Contracted Production Launch for Estimated $3,000,000 of UST-Processed, Nanoemulsified CBD Spray for Oral Use
From Pressure BioSciences Inc.
Via AccessWire
Tickers PBIO
Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market
From Pressure BioSciences Inc.
Via AccessWire
Tickers PBIO
Emerging Technology Insider Releases New TechTalks Video Interview with Pressure BioSciences' CEO Richard T. Schumacher
From Pressure BioSciences Inc.
Via AccessWire
Tickers PBIO
Pressure BioSciences, Inc. Reports Q1 2022 Financial Results
From Pressure BioSciences Inc.
Via AccessWire
Topics Economy
Exposures COVID-19 Supply Chain
Tickers PBIO
Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers PBIO
Pressure BioSciences to Present at the Planet MicroCap Showcase 2022 on May 4, 2022
From Pressure BioSciences Inc.
Via AccessWire
Tickers PBIO
Pressure BioSciences Announces Early Access Program for UST Nanoemulsion Processing
From Pressure BioSciences Inc.
Via AccessWire
Tickers PBIO
Pressure BioSciences to Discuss Recent Achievements and Upcoming Commercialization of its Enabling UST Platform at the Sequire Cannabis & Psychedelics Conference
From Pressure BioSciences Inc.
Via AccessWire
Topics Cannabis
Exposures Cannabis
Tickers PBIO
Pressure BioSciences Leveraging Strong FY2021 Operational and Financial Successes, Worldwide Customer Base, Substantial IP Estate, and Three Powerful Technology Platforms to Accelerate Strategic Company Transformation in 2022
From Pressure BioSciences Inc.
Via AccessWire
Tickers PBIO
Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2021 Financial Results and Provide Business Update
From Pressure BioSciences Inc.
Via AccessWire
Tickers PBIO
Pressure BioSciences Updates Stakeholders with Solid Progress on Key 2022 Goals: UST Commercial Release, Major Revenue Increase, Continued Financial Position Improvement, and Planned Uplist to National Market
From Pressure BioSciences Inc.
Via AccessWire
Tickers PBIO
Pressure BioSciences Ultra Shear Technology Commercialization Achieves Key Milestone: Production-Scale System Commissioned at Ohio State to Serve Food Industry
From Pressure BioSciences Inc.
Via AccessWire
Tickers PBIO
Pressure BioSciences to Participate in FORCE Family Office's January 20th Webinar: Innovations and Advancements in the $4.6 Billion CBD Market
From Pressure BioSciences Inc.
Via AccessWire
Tickers PBIO
Pressure BioSciences Shatters Preconceived Nanoemulsion Stability, Performance, and Production Limits: Produces CBD Oil Nanoemulsions with 18 Month Stability
From Pressure BioSciences Inc.
Via AccessWire
Tickers PBIO
Pressure BioSciences, Inc. Q3 Financial Results Maintain Solid 2021 YTD Growth
From Pressure BioSciences Inc.
Via AccessWire
Topics Earnings Regulatory Compliance
Exposures Financial Legal Regulatory
Tickers PBIO
Pressure BioSciences Awarded Second U.S. Patent for Its Revolutionary Ultra Shear Technology Platform, for Its Innovative NanoGap Valve
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures Intellectual Property Legal Regulatory
Tickers PBIO
Pressure BioSciences’ BaroFold Platform Unleashes Hidden Growth Engine as Strong Demand for Protein Therapeutics Leverages PBI’s Protein Refolding Technology
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures Intellectual Property Legal Regulatory
Tickers PBIO
Pressure BioSciences to Participate in the Benzinga ALL ACCESS Investor Event
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance Supply Chain
Exposures Intellectual Property Legal Regulatory
Tickers PBIO
Pressure BioSciences UST Platform Successfully Transforms Neem Oil into a Novel, Highly Potent Nanoemulsion for More Effective Agrochemical Applications
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Tickers PBIO
Pressure BioSciences Announces Forward Integration Plans for Ultra Shear Technology Demonstration and Toll Manufacturing Partnerships on U.S. West and East Coasts
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Tickers PBIO
Pressure BioSciences to Update Investors on Recent Accomplishments, Year-End Goals, Plans for Accelerating Revenue Growth, and Path to Profitability in 2022
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Tickers PBIO
Pressure BioSciences, Inc. Reports Strong Second Quarter 2021 Financial Results
From Pressure BioSciences Inc.
Via AccessWire
Topics Earnings Intellectual Property Regulatory Compliance
Exposures Financial Intellectual Property Legal
Tickers PBIO
Pressure BioSciences to Host Q2 2021 Financial Results and Business Update on Thursday, August 19, 2021
From Pressure BioSciences Inc.
Via AccessWire
Tickers PBIO
Pressure BioSciences to Expand on Recent Announcement of Over $1,000,000 in Orders Received by its New Eco-Friendly Agrochem Subsidiary in First Month of Operations
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Tickers PBIO
Pressure BioSciences New Eco-Friendly Agrochem Subsidiary Receives Over $1,000,000 in Orders in First Month of Operations
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Tickers PBIO
Pressure BioSciences Unveils Aggressive Growth Plan and Goals for Second Half 2021; Company Marches Toward UST Commercial Release, Up-listing, and Profitability
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures Intellectual Property Legal Product Safety
Tickers PBIO
Pressure BioSciences Announces Major Business Expansion, Establishing Eco-Friendly Agrochemicals Subsidiary and Initiating Plans to Drive Accretive 2021 Revenue
From Pressure BioSciences Inc.
Via AccessWire
Topics Regulatory Compliance Supply Chain
Exposures Legal Regulatory Supply Chain
Tickers PBIO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.